Sage Journals: Discover world-class research

Retricted access

Research article

First published 2003-10

Safety of COX-2 Inhibitors in Asthma Patients with Aspirin Hypersensitivity

Patricia M West, Cristina Fernández

Annals of Pharmacotherapy

Retricted access

Research article

First published 2004-06

For Discussion NSAIDs: gastroprotection or selective COX-2 inhibitor?

Andrew Dickman, John Ellershaw

Palliative Medicine

Retricted access

Research article

First published 2003-6

COX-2 Inhibitors: Effects on Blood Pressure in a Veterans Affairs Medical Center

Ellen Schellhase, Elizabeth Suryaatmaja, Tamara S. Evans

Hospital Pharmacy

Retricted access

Research article

First published 1999-10

Evaluation of Novel New NSAIDs: A Review of COX-2 Inhibitors,with an Emphasis on Gastrointestinal Toxicity

Julienne K. Kirk, Jennifer M. Hamilton, Kathy C. Phelps

Journal of Pharmacy Practice

Retricted access

Review article

First published 2010-9-10

Neuroinflammation in Alzheimer's Disease: Are NSAIDs and Selective COX-2 Inhibitors the Next Line of Therapy?

Catherine H. Trepanier, Norton W. Milgram

Journal of Alzheimer’s Disease

Free access

Review article

First published 2003-9

Cox-2 Selective Inhibitors and Bone

S. B. Goodman, T. Ma, M. Genovese [...]

International Journal of Immunopathology and Pharmacology

Retricted access

Research article

First published 2003-9

Adverse Drug Events Involving COX-2 Inhibitors

Margaret M Verrico, Robert J Weber, Teresa P McKaveney [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2016-3

Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery

Ehud Rath, Yaniv Warschawski, Eran Maman [...]

The American Journal of Sports Medicine

Free access

Research article

First published 2002-3

Celecoxib: A Specific COX-2 Inhibitor with Anticancer Properties

Alane T. Koki, Jaime L. Masferrer

Cancer Control

Free access

Research article

First published 2005-1

Proton Pump Inhibitor Co-Therapy Normalizes the Increased Cell Turnover of the Gastric Mucosa Both in Nsaid and Selective Cox-2 Users

I. Hritz, L. Herszenyi, B. Molnár [...]

International Journal of Immunopathology and Pharmacology

Search results